<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Jobpcr</title><link>http://www.jobpcr.com</link><description>Journal of Chemical and Pharmaceutical Research is an online international journal to promote all fields of Chemical Sciences like Organic Chemistry, Green Chemistry, Photochemistry, Inorganic Chemistry, Physical Chemistry, Industrial Chemistry, Biochemistry, Environmental Chemistry, Agricultural and Soil Chemistry, Analytical Chemistry, Polymer Chemistry, Macromolecular Chemistry, Petroleum Chemistry, Forensic Chemistry and Phytochemistry as well as all aspects of Chemical Engineering etc.</description><article><ArtTitle>
	Nanotech Combination Chemoprevention Study Against Balb/c Mice Implanted
	with Sarcoma 180 Cancer Cells
</ArtTitle><PubName>Journal of Biological ,Pharmaceutical And Chemical Research</PubName><JournalName>Journal of Biological ,Pharmaceutical And Chemical Research</JournalName><EISSN>2394-3076</EISSN><year>2016</year><volume>3</volume><issue>2</issue><AuthorName>
	Sharad Medhe, Prachi Bansal and ManMohan Srivastava*
	Page No. 1-12
</AuthorName><PageNo>1</PageNo><Abstract>
	Cancer is one of the most dreaded diseases in 21st century. Nanoparticle based therapeutics exhibit
	more benefits when compared to its active phytoconstituent alone. It also widely used as an efficient
	chemotherapeutic agent for the treatment of cancer and related diseases. The present work has
	designed to test in vivo anticancer activity of gold nanoparticle embeded 3,6-dihydroxyflavone
	(GNDHF); lutein (LUT) and selenium methyl selenocysteine (MSC) in single and combination
	against sarcoma 180 cancer cells induced in female inbred Balb/c mice strain. In vivo anticancer
	activity was evaluated by antigenotoxic (Chromosomal aberrations test, Micronucleus test) and
	Physical observation ((Body weight, tumor volume and tumor delay time)) of Balb/c mice strain.
	The antioxidant assays were determined by reduced glutathione (GSH) and Lipid Peroxidation
	(LPO) assay. Among the various treatment considered for the study, combination of (GNDHF: LUT:
	MSC) 5mg/Kg body weight dose exhibited optimum antioxidant activity (0.110.54 M) GSH per
	mg protein while (0.1870.74 nM) MDA per mg wet weight and rendered significant protection
	against oxidative stress induced by sarcoma 180 cancer cells in liver tissues. Combination
	(GNDHF: LUT: MSC) significantly suppresses the tumor growth in terms of body weight: 28.12
	gm1.04; tumor volume; 70.12 mm3 (42 % inhibition) at 5mg/Kg body weight dose. The study
	highlights that the combination of (GNDHF: LUT: MSC) is more promising cytotoxic bioagent
	against sarcoma 180 cancer cells induced in female Balb/c mice compared to the single compound
	and has enough potential for clinical applications.
	Key words: Nanoparticle; Combination study; in vivo; Oxidative stress.
</Abstract><URLs><abstract>http://www.jobpcr.com/archive-abs.php?arc=269</abstract><Fulltext><pdf>http://www.jobpcr.com/archive/JOBPCR-2016-3-2-045-4-12.pdf</pdf></Fulltext></URLs></article></channel></rss>
